Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission
ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission

Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align on the regulatory path forward for Anktiva in an additional indication

Notes on President Trump's Davos Speech: https://staticx-tuner.zacks.com/images/articles/main/84/143058.webp
Notes on President Trump's Davos Speech

Wednesday, January 21st, 2026President Trump has arrived in Davos, Switzerland this morning, and presently at the podium for the annual World Economic Forum. This is, quite succinctly, the main even

Riot Platforms: A $311M AMD Deal Changes the HPC Game: https://www.marketbeat.com/logos/articles/med_20260120120454_riot-platforms-a-311m-amd-deal-changes-the-hpc-gam.png
Riot Platforms: A $311M AMD Deal Changes the HPC Game

In mid-January, the financial markets witnessed a notable anomaly. While Bitcoin's ($BTC) price faced significant downward pressure, dropping toward $91,000 due to rising geopolitical tensions

Can Vertiv's International Expansion Drive More Upside in the Stock?
Can Vertiv's International Expansion Drive More Upside in the Stock?

Vertiv VRT is benefiting from strong international demand for data center infrastructure, driven by the global acceleration of digital transformation and AI adoption. The company reported a robust

Can B&G Foods' Margin Improvement Hold Amid Soft Demand?
Can B&G Foods' Margin Improvement Hold Amid Soft Demand?

B&G Foods, Inc.’s BGS third-quarter fiscal 2025 results reflect a difficult operating backdrop. Net sales declined 4.7% year over year to $439.3 million, while base business net sales, excluding

FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate
FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate

Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC), sofetabart mipitecan

SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?
SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?

SIFCO Industries, Inc.'s SIF investors have been experiencing some short-term losses from the stock of late. Shares of the Cleveland, OH-based manufacturer of forgings, sub-assemblies and machined

J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales
J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales

Johnson & Johnson’s JNJ fourth-quarter 2025 earnings came in at $2.46 per share, which beat the Zacks Consensus Estimate of $2.43. Earnings rose 20.6% from the year-ago period.

Adjusted earnings

Precious Metal ETF (DBP) Hits New 52-Week High
Precious Metal ETF (DBP) Hits New 52-Week High

Invesco DB Precious Metals ETF DBP is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 88.86% from its 52-week low price of $62.84 per share.

GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout
GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout

GSK plc GSK announced that it has entered into a definitive agreement to acquire California-based biotech RAPT Therapeutics RAPT for an estimated aggregate equity value of $2.2 billion.

The

Reasons Why You Should Retain Fiserv Stock in Your Portfolio
Reasons Why You Should Retain Fiserv Stock in Your Portfolio

Fiserv, Inc.’s FISV growth is fueled by the rising adoption of Software-as-a-Service (SaaS) and payment solutions by business houses. Its new acquisitions and AI innovations aid it in gaining access

Are Options Traders Betting on a Big Move in Caleres Stock?
Are Options Traders Betting on a Big Move in Caleres Stock?

Investors in Caleres, Inc. CAL need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $30 Call had some of the highest implied

HWC Q4 Earnings Beat Estimates on Fee Income & NII, Shares Dip
HWC Q4 Earnings Beat Estimates on Fee Income & NII, Shares Dip

Hancock Whitney Corp.’s HWC fourth-quarter 2025 earnings per share of $1.49 beat the Zacks Consensus Estimate by a penny. Further, the bottom line rose 6.4% from the prior year quarter.Results

Will Lower Active Accounts Impact Synchrony's Q4 Earnings Potential?
Will Lower Active Accounts Impact Synchrony's Q4 Earnings Potential?

Consumer financial services company, Synchrony Financial SYF, is set to report fourth-quarter 2025 results on Jan. 27, before the opening bell. The Zacks Consensus Estimate for the to-be-reported

Can PANW's Secure Browser Adoption Support Long-Term SASE Growth?
Can PANW's Secure Browser Adoption Support Long-Term SASE Growth?

Palo Alto Networks PANW is seeing strong growth in its Secured Access Service Edge (SASE) business, and secure browsers are becoming a bigger part of that story. In the first quarter of fiscal 2026

Implied Volatility Surging for Aris Mining Stock Options
Implied Volatility Surging for Aris Mining Stock Options

Investors in Aris Mining Corporation ARMN need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $5 Call had some of the highest

NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell Therapies
NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell Therapies

Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on developing next-generation cellular medicines for diabetes.

The companies have

Zacks Initiates Coverage of Altigen With Neutral Recommendation
Zacks Initiates Coverage of Altigen With Neutral Recommendation

Zacks Investment Research has recently initiated coverage of Altigen Communications, Inc. ATGN with a Neutral recommendation, spotlighting both its promising strategic developments and ongoing

Reasons Why You Should Retain Docusign Stock in Your Portfolio
Reasons Why You Should Retain Docusign Stock in Your Portfolio

Docusign DOCU has a Growth Score of A, which condenses key financial metrics to reflect a fair sense of the quality and sustainability of its growth.

The company’s fourth-quarter fiscal 2026

Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer
Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer

Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary Matrix-M adjuvant technology for use in up to two disease areas. The

Can HCA Q4 Earnings Withstand Higher Costs & Lower Outpatient Cases?
Can HCA Q4 Earnings Withstand Higher Costs & Lower Outpatient Cases?

Hospital operator HCA Healthcare, Inc. HCA is set to report fourth-quarter 2025 results on Jan. 27, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s

Is T Stock a Smart Investment Option Before Q4 Earnings Release?
Is T Stock a Smart Investment Option Before Q4 Earnings Release?

AT&T Inc. T is scheduled to report fourth-quarter 2025 earnings on Jan. 28, before the opening bell. The Zacks Consensus Estimate for revenues and earnings is pegged at $32.75 billion and 47 cents

Is the Options Market Predicting a Spike in European Wax Center Stock?
Is the Options Market Predicting a Spike in European Wax Center Stock?

Investors in European Wax Center, Inc. EWCZ need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $7 Put had some of the highest

Gold ETFs Glitter Amid Renewed Transatlantic Trade Strains
Gold ETFs Glitter Amid Renewed Transatlantic Trade Strains

January has already seen a fair share of market volatility, underscoring the year’s turbulent start and potentially setting the tone for what lies ahead in the months to come, while strengthening

Implied Volatility Surging for J.B. Hunt Transport Services Stock Options
Implied Volatility Surging for J.B. Hunt Transport Services Stock Options

Investors in J.B. Hunt Transport Services, Inc. JBHT need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $80 Put had some of the